Charles Munger, the alter ego, sidekick and foil to Warren Buffett for almost 60 years as they transformed

Rasmus Hojlund says Manchester United must stick together if they are to emerge from a “tough period” that has put Erik ten Hag’s side under intense scrutiny and pressure. Having won the Carabao Cup, reached the FA Cup final and finished third during the Dutchman’s first campaign in change, things have gone dramatically awry this term. United have lost four of their opening seven matches for the first time in the Premier League era and are pointless after their first two Champions League group games. There was no disgrace in the 4-3 loss at Bayern Munich a fortnight ago, but Tuesday’s 3-2 collapse at home to a Galatasaray side that had never won in England before is something else. “Of course it’s not about the individual performance,” Hojlund said. “It’s about getting the three points and at the moment we’re not doing good enough. “We need to remember we can’t get goals (go in) right after we score. “We’ve had a few games now where they just score after we scored. “We need to go back and analyse that tomorrow and talk about it in the group. “Of course it’s a tough period now but we need to stick together and that’s the only way we can get out of this period.” Hojlund opened the scoring on Tuesday with his first Old Trafford goal, only for grinning former United forward Wilfried Zaha to level for Galatasaray. Summer signing Hojlund raced through to score a superb second after he saw an earlier effort ruled out for offside, but Kerem Akturkoglu quickly equalise for the visitors. That goal sent United into a tailspin. Andre Onana’s horror pass led to Casemiro getting a red card and the Turkish champions winning a penalty, which Mauro Icardi missed but quickly atoned for when racing through to dink home. “We need to get some points now if we want to play in Champions League after the group stage,” Hojlund said ahead of matches home and away to former club FC Copenhagen. “I am looking forward to playing against them because it’s a former club, my brothers are playing there, and I have a big heart for Copenhagen. “But now I play in Manchester United and we need to get some points out of them.” United players kept their heads down as they walked through interview area after a chastening loss in which Hojlund’s display was the only highlight. The Old Trafford giants went for promise over a proven goalscorer when signing the 20-year-old international from Atalanta in the summer and he enjoyed his breakout moment on Tuesday. I like to call that a signature Rasmus goal Rasmus Hojlund on his second goal “It’s about getting in there,” Hojlund told MUTV. “For me, I always try to get into the dangerous positions. “Today I got the ball three times (there), if you count the offside goal as well. “I’ve been bought to be scoring goals and now I was happy to score two today. “Marcus (Rashford) and I talk to each other and he knows that I’m going to be there. “He knows that I can keep up with his pace when we go on the counter and we saw a glimpse of that today. “(The second goal) was a good feeling. I got cheated a little bit before because of the offside (with my second goal) but, yeah, it was an incredible goal. “I like to call that a signature Rasmus goal – on the left side, running a lot so, yeah, it was nice.” Read More Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live Football rumours: Jadon Sancho keeping contact with Borussia Dortmund On this day in 2008: Leeds beat St Helens to win Super League Grand Final Dan Sheehan says Ireland ‘fully aware of what we need to do’ against Scotland

DUBAI, United Arab Emirates--(BUSINESS WIRE)--May 15, 2023--

A federal appeals court will reconsider its March ruling that Tesla CEO Elon Musk unlawfully threatened employees with a loss of stock options in a 2018 Twitter post

Two new operator skins are dropping in Call of Duty: Vanguard and Warzone Pacific for the launch of Season 3 event "Operator Monarch." Here's how to get both the Godilla and King Kong Operator skins in CoD: Warzone and Vanguard.

By Andrew Gray and Bart H. Meijer BRUSSELS (Reuters) -European Union leaders gathered on Thursday to discuss the aborted mutiny

COLOMBO Sri Lanka plans to complete free trade talks with Thailand by February and sign an agreement in

The menopause treatment fezolinetant has been predicted as a “gamechanger” by experts for thousands of women who suffer from hot flushes. The drug, which is the first non-hormonal menopause treatment, was recently approved by America’s FDA. Experts are predicting it could be transformative for women for whom hormone replacement drugs (HRT) are not suitable. The drug was licensed in the US on 12 May and could be approved for use in the UK by the end of the year. According to a British Menopause Society survey, 79 per cent of women aged 45 to 65 experienced hot flushes as a result of their menopause transition, while 10 to 20 per cent describe the hot flushes as “near intolerable”. Here’s everything you need to know about fezolinetant: What is it used to treat? It works to target the menopause symptom of hot flushes. The drug that has been approved by the FDA is made by pharmaceutical company Astella, which advises patients to take one 45-milligram of its VEZOAH (fezolinetant) pill orally, once a day. A large clinical trial of fezolinetant published earlier this year revealed that, after 12 weeks of use, it reduced the frequency of hot flushes by about 60 per cent in women with moderate or severe symptoms, in comparison to a 45 per cent reduction in those who received a placebo. Women involved in the trial also said the drug reduced the severity of hot flushes and improved the quality of their sleep. How does it work? It works by blocking a brain protein called neurokinin-3, which plays a unique role in regulating body temperature in menopausal women. Respondents of the trial have said that the effects of the drug was experienced after taking the first tablet. By comparison, HRT, taken to alleviate menopausal symptoms, replaces the oestrogen that you lose during the menopause transition, either alone or in combination with a progestogen What are the side effects? According to the FDA, the most common side effects are abdominal pain, diarrhoea, insomnia, back pain, hot flush and elevated hepatic transaminases. What have experts said about it? “This is going to be a completely blockbuster drug,” said Prof Waljit Dhillo, an endocrinologist at Imperial College London who led a trial for the drug in 2017 toldThe Guardian. “It’s like a switch. Within a day or two the flushes go away. It’s unbelievable how well these drugs work. It’s going to be completely game changing for a lot of women.” Read More Adenomyosis: 5 things you need to know about the ‘evil twin sister’ of endometriosis ‘Suddenly, I saw Dad again’: The radical technology helping those living with dementia Naga Munchetty reveals womb condition adenomyosis: ‘I live every day on painkillers’

Yankees manager Aaron Boone was ejected for the fourth time this season and second time in a four-game span when he argued with Edwin Moscoso over the umpire’s strike zone during a game against the Baltimore Orioles

MANILA The International Monetary Fund (IMF) cut its economic growth forecast for the Philippines this year to 5.3%

MORRISTOWN, N.J.--(BUSINESS WIRE)--Nov 8, 2023--

Jake Fraley hit a tiebreaking, two-run homer in the eighth inning, and the Cincinnati Reds extended their majors-best winning streak to 11 games, rallying past the Colorado Rockies 5-3 for a three-game sweep